UNSPSC 51283960: Ditolamide

This classification denotes a sulfonamide anti-infective agent with the molecular formula C13H21NO2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AL8499KM94, chemically known as 4-methyl-n,n-dipropyl-benzenesulfonamide but more generally known as ditolamide, which bears US NIH Compound Identifier 208847. European Medicines Agency schedules Ditolamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06335MIG. The term DITOLAMIDE is an International Non-Proprietary Name.

DITOLAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: S(=O)(=O)(N(CCC)CCC)C1CCC(CC1)C.

UNSPSC 51283960 Ditolamide, a Commodity code, does not align with the state and local procurement activity currently tagged under it. The recent opportunities attributed to this code involve naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, medical and first aid supplies for emergency response, and generic pharmaceuticals and over-the-counter products — none of which are ditolamide, an industrial chemical compound. The mismatch suggests either a classification error in the source data or that ditolamide procurement is extremely limited among state and local buyers.

The issuing bodies soliciting pharmaceutical and medical supply products — Seminole County, Florida; the Texas Health and Human Services Commission; the City of Tampa; and the Minnesota Multistate Cooperative Purchasing Alliance — represent a mix of county health departments, state health agencies, municipal fire departments, and cooperative purchasing consortiums. Geographically, recent activity clusters in Florida, Texas, and Minnesota, with broader multistate coverage through the MMCAP cooperative vehicle. Representative solicitations include Seminole County's IFB for naloxone and drug deactivation systems (1,900 units of naloxone and 800 units of deactivation systems annually, due July 26, 2023), the City of Tampa's IFB for medical and first aid supplies intended for the Tampa Fire Department Rescue Division (169 line items, estimated contract value $700,000, due March 13, 2026), the Texas HHS Commission's RFI on direct-to-manufacturer prescription programs (posted April 3, 2026), and MMCAP's RFP for generic multi-source pharmaceuticals and OTC products (proposals due March 26, 2026). The code shows no recent activity actually attributable to ditolamide procurement at the state and local level.